PIN76 - Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

Autor: Westerhout, KY, Bouwmeester, W, Duchesne, I, Sbarigia, U, Pisini, M, Treur, M
Zdroj: In Value in Health November 2015 18(7):A589-A589
Databáze: ScienceDirect
Externí odkaz: